Brief: Cipher says Health Canada has approved Beteflam
07/12/2015 12:57
Dec 7 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO : * Receives Health Canada approval of (Pr)Beteflam(TM) * Says once the product is launched in Q2 2016, Beteflam is expected to be fourth marketed product in Canada * Source text for Eikon ID:nCNWLhb2fa * Further company coverage CPH.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million